PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-836

It is frustrating PAA is running a month late with the recruitment, but it is happening and by their past standards (remember the "imminent" results from the Netherlands for example?) that's actually pretty good. Understand fully the frustration this is causing and have agreed with a lot of your criticisms about the order they've done things and the poor messaging NZT, but then I bear in mind as always that I'm ignorant about what's gojng on behind the scenes and hindsight is a wonderful thing. but we really should focus on what's happening now. The most important thing at the moment is that they are recruiting for the MND trial, contrary to what some have been suggesting here, and how this will,pave the way for further human trials in other areas. Oh, and those legacy IPs owned by big pharma, they expire next year and the year after.